MAPT and Alzheimer disease: It has become crucial to monitor sleep of healthy elderly subjects over time to draw a continuous line of sleep-related changes in association with cognitive decline and the known markers of AD pathogenesis, such as beta amyloid (Aβ) and tau protein.